SB-200646
SB-200646 is a 5-HT2 receptor antagonist with anxiolytic properties in rats. It was the first 5-HT2 antagonist discovered to have selectivity of 5-HT2C/2B over 5-HT2A.[1]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H14N4O |
Molar mass | 266.304 g·mol−1 |
3D model (JSmol) | |
| |
|
References
- Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP (March 1994). "In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist". British Journal of Pharmacology. 111 (3): 797–802. doi:10.1111/j.1476-5381.1994.tb14808.x. PMC 1910094. PMID 7912626.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.